Peter PLACHÝ, Roman PECHÁŇ

Klinika stomatológie a maxilofaciálnej chirurgie LF UK a OÚSA, Bratislava, prednosta prof. MUDr. P. Stanko, PhD.

SUMMARY
In recent yeares they have been includet in treatment for suppressing haemocoagulation new oral anticoagulants – NOAC. New oral anticoagulants are direct inhibitors of free thrombin so-called gatrans and direct inhibitors of activated factor Xa, the so-called xabans (6), they are also called direct anticoagulants. The indications for their use mainly non-valvular fibrilation and increased risk of venous thromboembolism. The advantage of these anticoagulants is a fast anticoagulant effect but also their resonance. Depending on the type of medicament, the anticoagulant effect lasts 24 hours, e.g. for epixaban and rivaroxaban and 36 to 48 hours, e.g. dabigatran. For dentist,this means that it is possible to extract the tooth 24 hours or 48 hours after taking NOAK. Again,the patient start to use the NOAC 24 hours after extraction. Accurate management for surgical procedurs in NOAC treated patients has been published by the relevant medical companies (www.arytmie.sk).
Key words: NOAC, gatrans, xabans.

Lek obz (Med Horizon), 2020, 69 (1): 29 – 31